Literature DB >> 29781463

Hepatic Arterial Infusion Pump: Complications and Nursing Management Regarding Use in Patients With Colorectal Cancer.

Deborah Italiano1.   

Abstract

BACKGROUND: The hepatic arterial infusion (HAI) pump is a treatment-delivery method based on the principle of targeting the tumor site directly and can be used alone or in combination with systemic chemotherapy.
OBJECTIVES: The intent of this article is to serve as a resource for oncology nurses to safely identify and manage HAI pump complications. These complications include seroma, flipped HAI pump, infection, changes in pressure and temperature, challenging access, dry pump, high residual volume, chemical hepatitis, risk of ulcer, and radiologic imaging considerations.
METHODS: The authors performed a literature review to provide a foundation for nurses to be able to manage HAI pump infusions.
FINDINGS: The literature review revealed minimal nursing resources to manage complications with an HAI pump. Resources to manage complications are crucial for safely administering medications and properly maintaining the function of the pump. Attention to patient education should be incorporated in nursing practice.

Entities:  

Keywords:  colorectal cancer; hepatic arterial infusion pump; hepatic artery; oncology nursing

Mesh:

Year:  2018        PMID: 29781463      PMCID: PMC7469260          DOI: 10.1188/18.CJON.340-346

Source DB:  PubMed          Journal:  Clin J Oncol Nurs        ISSN: 1092-1095            Impact factor:   1.027


  10 in total

1.  Hepatic artery access ports: recognizing and avoiding the problems.

Authors:  J K Wickremesekera; R J Cannan; R S Stubbs
Journal:  Aust N Z J Surg       Date:  2000-07

2.  Use of hepatic lines: their journey from percutaneous to implantable.

Authors:  Ruth E Martin
Journal:  J Infus Nurs       Date:  2002 Mar-Apr

Review 3.  Implanted hepatic arterial infusion pumps.

Authors:  Margaret K Callahan; Nancy E Kemeny
Journal:  Cancer J       Date:  2010 Mar-Apr       Impact factor: 3.360

Review 4.  Hepatic artery infusion pump in the treatment of liver metastases.

Authors:  Lisa Parks; Meghan Routt
Journal:  Clin J Oncol Nurs       Date:  2015-06       Impact factor: 1.027

5.  Perioperative Hepatic Arterial Infusion Pump Chemotherapy Is Associated With Longer Survival After Resection of Colorectal Liver Metastases: A Propensity Score Analysis.

Authors:  Bas Groot Koerkamp; Eran Sadot; Nancy E Kemeny; Mithat Gönen; Julie N Leal; Peter J Allen; Andrea Cercek; Ronald P DeMatteo; T Peter Kingham; William R Jarnagin; Michael I D'Angelica
Journal:  J Clin Oncol       Date:  2017-04-20       Impact factor: 44.544

6.  What is the potential role of hepatic arterial infusion chemo-therapy in the current armamentorium against colorectal cancer.

Authors:  Ozkän Kanat; Alexandra Gewirtz; Nancy Kemeny
Journal:  J Gastrointest Oncol       Date:  2012-06

Review 7.  Intrahepatic arterial infusion of chemotherapy: pharmacologic principles.

Authors:  William D Ensminger
Journal:  Semin Oncol       Date:  2002-04       Impact factor: 4.929

8.  Totally implanted system for intravenous chemotherapy in patients with cancer.

Authors:  J Gyves; W Ensminger; J Niederhuber; M Liepman; E Cozzi; K Doan; S Dakhil; R Wheeler
Journal:  Am J Med       Date:  1982-12       Impact factor: 4.965

9.  A randomized trial of intrahepatic infusion of fluorodeoxyuridine with dexamethasone versus fluorodeoxyuridine alone in the treatment of metastatic colorectal cancer.

Authors:  N Kemeny; K Seiter; D Niedzwiecki; D Chapman; E Sigurdson; A Cohen; J Botet; P Oderman; P Murray
Journal:  Cancer       Date:  1992-01-15       Impact factor: 6.860

10.  Phase II trial of hepatic artery infusional and systemic chemotherapy for patients with unresectable hepatic metastases from colorectal cancer: conversion to resection and long-term outcomes.

Authors:  Michael I DʼAngelica; Camilo Correa-Gallego; Philip B Paty; Andrea Cercek; Alexandra N Gewirtz; Joanne F Chou; Marinella Capanu; T Peter Kingham; Yuman Fong; Ronald P DeMatteo; Peter J Allen; William R Jarnagin; Nancy Kemeny
Journal:  Ann Surg       Date:  2015-02       Impact factor: 12.969

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.